Can a First-Trimester blood test catch pregnancy diabetes sooner?

NCT ID NCT05388643

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether screening for gestational diabetes in the first trimester (instead of the usual third trimester) can detect the condition earlier in high-risk pregnancies. Researchers will use a combination of risk factors and blood markers to predict GDM. The goal is to see if this early screening is practical and acceptable for pregnant women.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Enhanced first-trimester glucose screening with a prediction model using clinical risk factors and blood biomarkers (triglycerides, PAPP-A, lipocalin-2)
What this could lead to
If successful, this could lead to earlier detection and management of gestational diabetes, potentially reducing complications for mothers and babies.
What could go wrong
This is a small early feasibility study (80 participants), so results may not apply broadly. The screening test may not accurately predict GDM, leading to false positives or negatives.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS IN PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Massachusetts Memorial Medical Center

    RECRUITING

    Worcester, Massachusetts, 01605, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.